Conclusions: Nine in ten infants born with major CA will survive up to age five years, although there is variability in survival for chromosomal, syndromes, isolated, multiple and non-Q chapter CA. Survival information is valuable for counselling parents and planning of healthcare resources. 
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Background: Undetected fetal growth restriction (FGR) is the strongest risk factor for stillbirth. Identification of FGR, and timely delivery, is an important aspect of antenatal care. This prompted the inclusion within the Victorian Perinatal Services Performance Indicators, on births in 2010, of an annual performance indicator measuring the detection and management of severe FGR (<3 rd centile) in singleton pregnancies.
Methods:
We conducted a retrospective cohort study on all births in Victoria from 2000 to 2016 using the Victorian Perinatal Data Collection. We assessed the actual birthweight centiles of babies iatrogenically delivered for suspected FGR. Our outcomes of interest were gestation at delivery, birthweight centile, and type of labour. We employed descriptive statistics and chi-square test for linear trend.
Results: The percentage of severe FGR babies delivered ≥40 weeks' has decreased from 46.9% in 2000 to 30.7% in 2016 (P-value < 0.001). However, the number of pregnancies iatrogenically delivered for suspected FGR has increased from 741 pregnancies in 2000 to 2579 pregnancies in 2016. The percentage of these pregnancies that have an actual birthweight ≥10th centile has increased from 41.4% (n = 307) in 2000 to 51.0% (n = 1316) in 2016 (P-value < 0.001).
Conclusions: Severe FGR management has improved since publicly reporting this Victorian performance indicator. However, the improved detection of severe FGR has been accompanied by increased iatrogenic birth in non-growth restricted pregnancies. This suggests that the gains from improved FGR management may be offset by iatrogenic harm to normally grown babies via earlier delivery, induction of labour and pre-labour caesarean section. Background: In Australia, there has been no improvement in stillbirth rates for over 20 years and the national rate of 9.7 per 1000 is lagging behind other developed countries. The aim of this study is to develop an analytic foundation for an evidence-based approach to predict risk of stillbirth.
STILLBIRTH RISK PROFILE: SURVIVAL ANALYSIS THROUGHOUT GESTATION
Methods: Singleton birth data was collected through the EHR system at the Mater Mother's Hospital (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) (2016) (2017) (2018) in Brisbane and includes 110,940 livebirths and 749 stillbirths from 20-45 weeks gestation without congenital abnormalities. Descriptive and survival analyses were performed to assess variation in risk profile throughout gestation (week units) and to develop risk estimates.
Results: A stillbirth rate of 6.8 per 1000 livebirths was observed. Mean maternal age for both livebirths and stillbirth was 32 years. Average gestational age of 38 weeks was estimated for livebirths and 31 weeks for stillbirths. An elevated risk for stillbirth was observed among publicly-insured (OR 1.5, 95%CI 1.29-1.75), low-education (OR 1.73, 95%CI 1.50-2.01), diabetic (OR 1.69, 95%CI 1.42-2.02), and overweight (BMI>24.9, OR 1.5, 95%CI 1.29-1.74) women. Hypertensive disorders showed four-times increased risk of stillbirth (OR 4.13, ). Higher stillbirth proportions were observed among those with reported Indigenous status (OR 1.49, 95%CI 0.99-2.17) and sub-Saharan African ethnicity (OR 1.78, 95%CI 1.12-2.70) with stillbirth rates of 10.0 and 11.9 per 1000 livebirths, respectively.
Conclusions: Developing accurate risk factor estimates and understanding the stillbirth risk profile is an important step toward development of a risk prediction model. Counties Manukau Health, Auckland, New Zealand Email: rajesh.shah@auckland.ac.nz Background: Hypoglycaemia is the most common metabolic problem in neonates but there is no universally accepted threshold for safe blood glucose concentrations due to uncertainty regarding effects on neurodevelopment.
Methods: We searched MEDLINE, EMBASE, CINAHL, and PsycINFO from inception until February 2018. We included studies that reported one or more pre-specified outcome and compared children exposed to neonatal hypoglycaemia with children not exposed. Studies of neonates with congenital malformations, inherited metabolic disorders and congenital hyperinsulinism were excluded. Two authors independently extracted data using a customised form. We used ROBINS-I to assess risk of bias, GRADE for quality of evidence, and REVMAN for meta-analysis (inverse variance, fixed effects). Separate meta-analysis was planned for early childhood (2-5y), mid-childhood (6-11y) and adolescence.
Results: 1665 studies were screened, 61 reviewed in full, and 11 included (12 publications). In early childhood, exposure to neonatal hypoglycaemia was not associated with neurodevelopmental impairment (N = 1657 infants; OR = 1.16, 95%CI 0.86-1.57) but was associated with visual-motor impairment (N = 508; OR = 3.46, 95%CI 1.13-10.57) and executive
